NASDAQ:MGLN - Magellan Health Stock Price, News, & Analysis

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

Magellan Health Inc (NASDAQ:MGLN) released its earnings results on Thursday, May, 2nd. The company reported $0.40 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.34 by $0.06. The firm earned $1.74 billion during the quarter, compared to analyst estimates of $1.75 billion. Magellan Health had a net margin of 0.18% and a return on equity of 3.83%. The business's revenue was down 3.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.81 EPS. View Magellan Health's Earnings History.

Magellan Health is scheduled to release their next quarterly earnings announcement on Friday, July 26th 2019. View Earnings Estimates for Magellan Health.

Magellan Health issued an update on its FY19 earnings guidance on Thursday, May, 2nd. The company provided earnings per share (EPS) guidance of $3.70-4.69 for the period, compared to the Thomson Reuters consensus estimate of $3.92. The company issued revenue guidance of $7.0-7.2 billion, compared to the consensus revenue estimate of $7.22 billion.

4 equities research analysts have issued 1 year target prices for Magellan Health's shares. Their forecasts range from $68.00 to $84.00. On average, they expect Magellan Health's share price to reach $73.50 in the next twelve months. This suggests a possible upside of 12.2% from the stock's current price. View Analyst Price Targets for Magellan Health.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health.

Press coverage about MGLN stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Magellan Health earned a daily sentiment score of 1.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Magellan Health.

Some companies that are related to Magellan Health include Encompass Health (EHC), Healthscope (HSO), MEDNAX (MD), Select Medical (SEM), Primary Health Care (PRY), Medical Facilities (DR), Capitol Health (CAJ), Animalcare Group (ANCR), SunLink Health Systems (SSY), Spine Injury Solutions (SPIN) and THC Biomed Intl (THC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer LP Unit (ET), Netflix (NFLX), Ford Motor (F), CBL & Associates Properties (CBL), ConocoPhillips (COP), Edwards Lifesciences (EW), UnitedHealth Group (UNH), Cornerstone Total Return Fund (CRF), Abeona Therapeutics (ABEO) and Cypress Semiconductor (CY).

Magellan Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Victory Capital Management Inc. (3.04%), Parametric Portfolio Associates LLC (1.20%), William Blair Investment Management LLC (0.81%), JPMorgan Chase & Co. (0.80%), Smith Graham & Co. Investment Advisors LP (0.71%) and 13D Management LLC (0.63%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

MGLN stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, Kennedy Capital Management Inc., Victory Capital Management Inc., Marshall Wace LLP, William Blair Investment Management LLC, First Quadrant L P CA, Cambiar Investors LLC and New York State Teachers Retirement System. View Insider Buying and Selling for Magellan Health.

MGLN stock was purchased by a variety of institutional investors in the last quarter, including 13D Management LLC, 13D Management LLC, Parametric Portfolio Associates LLC, Assenagon Asset Management S.A., FMR LLC, JPMorgan Chase & Co., SG Americas Securities LLC and Alpine Associates Management Inc.. View Insider Buying and Selling for Magellan Health.

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MGLN stock can currently be purchased for approximately $65.48.

Magellan Health has a market capitalization of $1.57 billion and generates $7.31 billion in revenue each year. The company earns $24.18 million in net income (profit) each year or $2.44 on an earnings per share basis. Magellan Health employs 10,500 workers across the globe.View Additional Information About Magellan Health.

The official website for Magellan Health is http://www.magellanhealth.com/.

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]